Reuters: Device to treat atrial fibrillation superior: study

[NaDiNe]

Device to treat atrial fibrillation superior: study
      

CHICAGO (Reuters) - Johnson &amp; Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S. regulatory approval for the treatment, J&amp;J said on Tuesday.</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login